Congyang HUANG, Hanshan LİU, Honglian HU, Li JİA, Suyun HU

Health insurance status and outcomes in children, adolescents, and young adults: a systematic review and meta-analysis

Background. The impacts of health insurance status on survival outcomes in children, adolescents, and young adults (aged 0-39 years) with malignant tumors have not been addressed in depth. The present study aimed to identify significant relationships of health insurance condition with overall survival or all-cause mortality among children (age 0–14 years) and adolescents and young adults (AYAs, age 15–39 years) with malignant tumors. Methods. PubMed, Wiley Cochrane Central Register of Controlled Trials, Econlit, CINAHL, Web of Knowledge, PsychInfo, Business Source Premier, ProQuest Dissertation & Theses Database, and SCOPUS were systematically searched from inception to February 29, 2020 with no language restriction. All related articles comparing the effect of health insurance status on the risk of overall survival and the risk of all-cause mortality in malignant conditions affecting children and AYAs were identified. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were computed using a random- or fixed-effect model as per the heterogeneity evaluated using Cochran’s Q and I2 statistics. Results. Fourteen studies including 149,680 individuals were selected for this meta-analysis. The pooled RR for all-cause mortality with insurance versus without insurance was 0.78 (95%CI, 0.71–0.86; I2=33.7%). Among the insurance types, patients with private insurance presented with a lower all-cause mortality (RR 0.70, 95% CI 0.60–0.82), with considerable heterogeneity (I2=83.3%). Conclusions. The findings of this review suggest that a lack of or insufficient insurance is related to all-cause mortality of AYAs with malignant cancers. Strategies aimed at identifying causality and reducing disparities are warranted.

PDF

___

1. Pritchard-Jones K, Pieters R, Reaman GH, et al. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from highincome countries. Lancet Oncol 2013; 14: e95-e103.

2. Bleyer A. The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 2005; 35: 182-217.

3. Global Burden of Disease Child and Adolescent Health Collaboration, Kassebaum N, Kyu HH, Zoeckler L,, et al.Child and adolescent health from 1990 to 2015: findings from the global burden of diseases, injuries, and risk factors 2015 Study. JAMA Pediatr 2017; 171: 573-592.

4. Patton GC, Coffey C, Sawyer SM, et al. Global patterns of mortality in young people: a systematic analysis of population health data. Lancet 2009; 374: 881-892.

5. Abdul-Razak S, Azzopardi PS, Patton GC, Mokdad AH, Sawyer SM. Child and adolescent mortality across Malaysia’s epidemiological transition: a systematic analysis of global burden of disease data. J Adolesc Health 2017; 61: 424-433.

6. Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep 2013; 62: 1-96.

7. Sidebotham P, Fraser J, Fleming P, Ward-Platt M, Hain R. Patterns of child death in England and wales. Lancet 2014; 384: 904-914.

8. Bleyer A, Ferrari A, Whelan J, Barr RD. Global assessment of cancer incidence and survival in adolescents and young adults. Pediatr Blood Cancer 2017; 64.

9. Mogensen H, Modig K, Tettamanti G, Erdmann F, Heyman M, Feychting M. Survival after childhood cancer-social inequalities in high-income countries. Front Oncol 2018; 8: 485.

10. Stones DK, De Bruin GP, Esterhuizen TM, Stefan DC. Childhood cancer survival rates in two South African units. S Afr Med J 2014; 104: 501-504.

11. Keegan TH, Grogan RH, Parsons HM, et al. Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California. Thyroid 2015; 25: 635- 648.

12. James SL, Castle CD, Dingels ZV, et al. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017. Inj Prev 2020; 26(Suppl 1): i165.

13. Aizer AA, Falit B, Mendu ML, et al. Cancer-specific outcomes among young adults without health insurance. J Clin Oncol 2014; 32: 2025-2030.

14. Keegan TH, DeRouen MC, Parsons HM, et al. Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: a population-based study. Cancer Epidemiol Biomarkers Prev 2016; 25: 264-273.

15. Fintel AE, Jamy O, Martin MG. Influence of insurance and marital status on outcomes of adolescents and young adults with acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 2015; 15: 364-367.

16. Kent EE, Sender LS, Largent JA, Anton-Culver H. Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors. Cancer Causes Control2009; 20: 1409-1420.

17. Docrat S, Besada D, Cleary S, Lund C. The impact of social, national and community-based health insurance on health care utilization for mental, neurological and substance-use disorders in lowand middle-income countries: a systematic review. Health Econ Rev 2020; 10: 11.

18. Takagi H, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Worse survival after transcatheter aortic valve implantation than surgical aortic valve replacement: a meta-analysis of observational studies with a propensity-score analysis. Int J Cardiol 2016; 220: 320-327.

19. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.

20. Hedges LV, Pigott TD. The power of statistical tests in meta-analysis. Psychol Methods 2001; 6: 203-217.

21. Abrahão R, Keogh RH, Lichtensztajn DY, et al. Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study. Br J Haematol 2016; 173: 292-302.

22. Akhavan A, Richards M, Shnorhavorian M, Goldin A, Gow K, Merguerian PA. Renal cell carcinoma in children, adolescents and young adults: a National Cancer Database study. J Urol 2015; 193: 1336-1341.

23. Lee DY, Teng A, Pedersen RC, et al. Racial and socioeconomic treatment disparities in adolescents and young adults with stage II-III rectal cancer. Ann Surg Oncol 2017; 24: 311-318.

24. DeRouen MC, Parsons HM, Kent EE, Pollock BH, Keegan THM. Sociodemographic disparities in survival for adolescents and young adults with cancer differ by health insurance status. Cancer Causes Control 2017; 28: 841-851.

25. Martijn HA, Njuguna F, Olbara G, et al. Influence of health insurance status on paediatric non-Hodgkin’s lymphoma treatment in Kenya. BMJ Paediatr Open 2017; 1: e000149.

26. Garner EF, Maizlin II, Dellinger MB, et al. Effects of socioeconomic status on children with welldifferentiated thyroid cancer. Surgery 2017; 162: 662-669.

27. Njuguna F, Martijn HA, Kuremu RT, et al. Wilms tumor treatment outcomes: perspectives from a lowincome setting. J Glob Oncol 2017; 3: 555-562.

28. Bownes LV, Stafman LL, Maizlin II, et al. Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population. J Surg Res 2018; 222: 180-186.e3.

29. Penumarthy NL, Goldsby RE, Shiboski SC, Wustrack R, Murphy P, Winestone LE. Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas. Cancer Med 2020; 9: 951-958.

30. Mitchell HK, Morris M, Ellis L, Abrahão R, Bonaventure A. Racial/ethnic and socioeconomic survival disparities for children and adolescents with central nervous system tumours in the United States, 2000-2015. Cancer Epidemiol 2020; 64: 101644.

31. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg2013; 148: 516-523.

32. Keegan TH, Tao L, DeRouen MC, et al; AYA HOPE Study Collaborative Group. Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers? J Cancer Surviv 2014; 8: 282-292.

33. Smith AW, Bellizzi KM, Keegan TH, et al. Healthrelated quality of life of adolescent and young adult patients with cancer in the United States: the adolescent and young adult health outcomes and patient experience study. J Clin Oncol 2013; 31: 2136- 2145

34. Gorey KM, Luginaah IN, Holowaty EJ, Zou G, Hamm C, Balagurusamy MK. Mediation of the effects of living in extremely poor neighborhoods by health insurance: breast cancer care and survival in California, 1996 to 2011. Int J Equity Health 2013; 12: 6.

35. Yabroff KR, Dowling EC, Guy GP Jr, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 2016; 34: 259-267.

36. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 2013; 18: 381-390.

37. Wu XC, Lund MJ, Kimmick GG, et al. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 2012; 30: 142-150.

38. Chae DH, Nuru-Jeter AM, Adler NE, et al. Discrimination, racial bias, and telomere length in African-American men. Am J Prev Med 2014; 46: 103-111.

39. Tehranifar P, Neugut AI, Phelan JC, et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev 2009; 18: 2701-2708.

40. Keegan TH, DeRouen MC, Press DJ, Kurian AW, Clarke CA. Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res 2012; 14: R55.

41. Keegan TH, Press DJ, Tao L, et al. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. Breast Cancer Res 2013; 15: R95.

42. Bradley CJ, Gardiner J, Given CW, Roberts C. Cancer, medicaid enrollment, and survival disparities. Cancer 2005; 103: 1712-1718.